Copyright Reports & Markets. All rights reserved.

Global Aurora Kinase C Market Professional Survey Report 2019

Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Aurora Kinase C

      • 1.1 Definition of Aurora Kinase C
      • 1.2 Aurora Kinase C Segment by Type
        • 1.2.1 Global Aurora Kinase C Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 AMG-900
        • 1.2.3 Danusertib
        • 1.2.4 Ilorasertib
        • 1.2.5 NMI-900
        • 1.2.6 SAR-156497
        • 1.2.7 Others
      • 1.3 Aurora Kinase C Segment by Applications
        • 1.3.1 Global Aurora Kinase C Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Solid Tumor
        • 1.3.3 Non-Small Cell Lung Cancer
        • 1.3.4 Acute Lymphocytic Leukemia
        • 1.3.5 Others
      • 1.4 Global Aurora Kinase C Overall Market
        • 1.4.1 Global Aurora Kinase C Revenue (2014-2025)
        • 1.4.2 Global Aurora Kinase C Production (2014-2025)
        • 1.4.3 North America Aurora Kinase C Status and Prospect (2014-2025)
        • 1.4.4 Europe Aurora Kinase C Status and Prospect (2014-2025)
        • 1.4.5 China Aurora Kinase C Status and Prospect (2014-2025)
        • 1.4.6 Japan Aurora Kinase C Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Aurora Kinase C Status and Prospect (2014-2025)
        • 1.4.8 India Aurora Kinase C Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Aurora Kinase C
      • 2.3 Manufacturing Process Analysis of Aurora Kinase C
      • 2.4 Industry Chain Structure of Aurora Kinase C

      3 Development and Manufacturing Plants Analysis of Aurora Kinase C

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Aurora Kinase C Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Aurora Kinase C
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Aurora Kinase C Production and Capacity Analysis
      • 4.2 Aurora Kinase C Revenue Analysis
      • 4.3 Aurora Kinase C Price Analysis
      • 4.4 Market Concentration Degree

      5 Aurora Kinase C Regional Market Analysis

      • 5.1 Aurora Kinase C Production by Regions
        • 5.1.1 Global Aurora Kinase C Production by Regions
        • 5.1.2 Global Aurora Kinase C Revenue by Regions
      • 5.2 Aurora Kinase C Consumption by Regions
      • 5.3 North America Aurora Kinase C Market Analysis
        • 5.3.1 North America Aurora Kinase C Production
        • 5.3.2 North America Aurora Kinase C Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Aurora Kinase C Import and Export
      • 5.4 Europe Aurora Kinase C Market Analysis
        • 5.4.1 Europe Aurora Kinase C Production
        • 5.4.2 Europe Aurora Kinase C Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Aurora Kinase C Import and Export
      • 5.5 China Aurora Kinase C Market Analysis
        • 5.5.1 China Aurora Kinase C Production
        • 5.5.2 China Aurora Kinase C Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Aurora Kinase C Import and Export
      • 5.6 Japan Aurora Kinase C Market Analysis
        • 5.6.1 Japan Aurora Kinase C Production
        • 5.6.2 Japan Aurora Kinase C Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Aurora Kinase C Import and Export
      • 5.7 Southeast Asia Aurora Kinase C Market Analysis
        • 5.7.1 Southeast Asia Aurora Kinase C Production
        • 5.7.2 Southeast Asia Aurora Kinase C Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Aurora Kinase C Import and Export
      • 5.8 India Aurora Kinase C Market Analysis
        • 5.8.1 India Aurora Kinase C Production
        • 5.8.2 India Aurora Kinase C Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Aurora Kinase C Import and Export

      6 Aurora Kinase C Segment Market Analysis (by Type)

      • 6.1 Global Aurora Kinase C Production by Type
      • 6.2 Global Aurora Kinase C Revenue by Type
      • 6.3 Aurora Kinase C Price by Type

      7 Aurora Kinase C Segment Market Analysis (by Application)

      • 7.1 Global Aurora Kinase C Consumption by Application
      • 7.2 Global Aurora Kinase C Consumption Market Share by Application (2014-2019)

      8 Aurora Kinase C Major Manufacturers Analysis

      • 8.1 AbbVie Inc
        • 8.1.1 AbbVie Inc Aurora Kinase C Production Sites and Area Served
        • 8.1.2 AbbVie Inc Product Introduction, Application and Specification
        • 8.1.3 AbbVie Inc Aurora Kinase C Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Amgen Inc
        • 8.2.1 Amgen Inc Aurora Kinase C Production Sites and Area Served
        • 8.2.2 Amgen Inc Product Introduction, Application and Specification
        • 8.2.3 Amgen Inc Aurora Kinase C Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Cielo Therapeutics Inc
        • 8.3.1 Cielo Therapeutics Inc Aurora Kinase C Production Sites and Area Served
        • 8.3.2 Cielo Therapeutics Inc Product Introduction, Application and Specification
        • 8.3.3 Cielo Therapeutics Inc Aurora Kinase C Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Sanofi
        • 8.4.1 Sanofi Aurora Kinase C Production Sites and Area Served
        • 8.4.2 Sanofi Product Introduction, Application and Specification
        • 8.4.3 Sanofi Aurora Kinase C Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served

      9 Development Trend of Analysis of Aurora Kinase C Market

      • 9.1 Global Aurora Kinase C Market Trend Analysis
        • 9.1.1 Global Aurora Kinase C Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Aurora Kinase C Regional Market Trend
        • 9.2.1 North America Aurora Kinase C Forecast 2019-2025
        • 9.2.2 Europe Aurora Kinase C Forecast 2019-2025
        • 9.2.3 China Aurora Kinase C Forecast 2019-2025
        • 9.2.4 Japan Aurora Kinase C Forecast 2019-2025
        • 9.2.5 Southeast Asia Aurora Kinase C Forecast 2019-2025
        • 9.2.6 India Aurora Kinase C Forecast 2019-2025
      • 9.3 Aurora Kinase C Market Trend (Product Type)
      • 9.4 Aurora Kinase C Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Aurora Kinase C Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Aurora Kinase C market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Aurora Kinase C volume and value at global level, regional level and company level. From a global perspective, this report represents overall Aurora Kinase C market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Aurora Kinase C in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Aurora Kinase C manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        AbbVie Inc
        Amgen Inc
        Cielo Therapeutics Inc
        Sanofi
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        AMG-900
        Danusertib
        Ilorasertib
        NMI-900
        SAR-156497
        Others

        Segment by Application
        Solid Tumor
        Non-Small Cell Lung Cancer
        Acute Lymphocytic Leukemia
        Others

        Buy now